Stemedica Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $1.11M

  • Investors
  • 7

Stemedica General Information

Description

Developer of adult allogeneic stem cell products designed for the treatment of individuals suffering from debilitating diseases and medical conditions. The company's products support two types of cells currently used for investigating stem cell therapies for degenerative diseases, including autologous and allogeneic, enabling patients to begin treatment more quickly and resulting in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6350 Nancy Ridge Drive
  • Suite 106
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6350 Nancy Ridge Drive
  • Suite 106
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stemedica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 12-Apr-2020 $1.11M Completed Clinical Trials - General
8. Merger/Acquisition 18-May-2018 Cancelled Startup
7. Later Stage VC Completed Startup
6. Later Stage VC (Series B) 14-Jul-2014 Completed Startup
5. Later Stage VC 09-Mar-2011 Completed Startup
4. Joint Venture 05-Oct-2010 Completed Startup
3. Early Stage VC 31-Dec-2009 Completed Startup
2. Early Stage VC (Series B) 12-May-2008 $10.1M $55.1M Completed Startup
1. Early Stage VC (Series A) 12-May-2008 $45M $45M Completed Startup
To view Stemedica’s complete valuation and funding history, request access »

Stemedica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of adult allogeneic stem cell products designed for the treatment of individuals suffering from debilitating d
Drug Discovery
San Diego, CA
30 As of 2021

Clarksville, MD
 

Aberdeen, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stemedica Competitors (9)

One of Stemedica’s 9 competitors is NeuroNascent, a Venture Capital-Backed company based in Clarksville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD
TauRx Pharmaceuticals Private Equity-Backed Aberdeen, United Kingdom
Curemark Venture Capital-Backed New York, NY
Brainstorm Cell Therapeutics Corporation New York, NY
Smart Cells International Corporate Backed or Acquired West Drayton, United Kingdom
You’re viewing 5 of 9 competitors. Get the full list »

Stemedica Patents

Stemedica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10973757-B2 Biodegardable microneedle device Inactive 06-Oct-2014
US-20120141433-A1 Vaporized stem cell derivatives for topical and other therapeutic uses Inactive 06-Oct-2010
WO-2011043844-A1 Compositions of stem cells and stem cell factors and methods for their use and manufacture Inactive 05-Oct-2009
US-20070154465-A1 Stem cell therapy for retinal disease Inactive 30-Dec-2005
US-20060282135-A1 Radiation separating shield for skin treatment Inactive 12-Jul-2004 H01S3/0675
To view Stemedica’s complete patent history, request access »

Stemedica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stemedica Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
GC Biopharma Corporation Minority
AnC Bio Group Corporation Minority
UBS Group Asset Manager Minority
FutureMED VENTURES Venture Capital Minority
ProMedica Innovations Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Stemedica FAQs

  • When was Stemedica founded?

    Stemedica was founded in 2006.

  • Where is Stemedica headquartered?

    Stemedica is headquartered in San Diego, CA.

  • What is the size of Stemedica?

    Stemedica has 30 total employees.

  • What industry is Stemedica in?

    Stemedica’s primary industry is Drug Discovery.

  • Is Stemedica a private or public company?

    Stemedica is a Private company.

  • What is Stemedica’s current revenue?

    The current revenue for Stemedica is .

  • How much funding has Stemedica raised over time?

    Stemedica has raised $82.1M.

  • Who are Stemedica’s investors?

    GC Biopharma, AnC Bio Group, UBS Group, FutureMED VENTURES, and ProMedica Innovations are 5 of 7 investors who have invested in Stemedica.

  • Who are Stemedica’s competitors?

    NeuroNascent, TauRx Pharmaceuticals, Curemark, Brainstorm Cell Therapeutics, and Smart Cells International are some of the 9 competitors of Stemedica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process